Federal Circuit Grants Arthrex Relief Despite Waiver Arguments

JD
Jones Day
Contributor
Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
On March 30, 2020, the Federal Circuit relied on Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019) to vacate and remand several related PTAB decisions, including in...
United States Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

On March 30, 2020, the Federal Circuit relied on Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019) to vacate and remand several related PTAB decisions, including in proceedings where the patent owner did not previously request Arthrex relief from the PTAB.

North Star Innovations, Inc. ("North Star") owns the challenged patents, which are directed generally to voltage-boosting circuits, ball-grid array (BGA) packaging, and memory controllers in data processing systems. Days before the Federal Circuit issued its ruling in Arthrex, the PTAB issued final written decisions in multiple IPR proceedings that invalidated the claims of North Star's patents.

North Star appealed to the Federal Circuit, and filed a motion asking the Court to vacate and remand the PTAB's decisions pursuant to Arthrex. The petitioner and the USPTO argued that North Star had waived its Arthrex argument by failing to first raise it with the PTAB in a rehearing request, where North Star's rehearing request window was open when the Arthrex decision issued. The petitioner also argued that North Star forfeited its right to press a constitutional challenge by objecting only the PTAB panel's unfavorable rulings while accepting a favorable decision in another proceeding before that same panel. However, the Federal Circuit rejected the petitioner's and the USPTO's arguments and granted North Star's motion.

Takeaway: A party may still be able obtain an Arthrex remand from the Federal Circuit even if they did not first request that relief from the PTAB during an open rehearing time window.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Federal Circuit Grants Arthrex Relief Despite Waiver Arguments

United States Intellectual Property
Contributor
Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More